ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Duo Zuo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0308-8525; OpenAlex author ID A5055422539. Sources: OpenAlex.

Their work

Papers: 5
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 19

Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 5

Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microenvironment in pancreatic cancer: a retro… Co-author DOI 10.21037/jgo-2025-283 ↗
KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. Co-author DOI 10.1007/s00018-024-05442-6 ↗
iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy Co-author DOI 10.21203/rs.3.rs-2470450/v1 ↗
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma. Co-author DOI 10.20892/j.issn.2095-3941.2020.0516 ↗
Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer. Co-author DOI 10.21037/atm-21-295 ↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenna Jiang · 4 shared papers, 2021–2025 · strength 0.70
Li Ren · 3 shared papers, 2021–2025 · strength 0.50
Lu Qiao · 2 shared papers, 2021–2024 · strength 0.33
- Paper KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. DOI 10.1007/s00018-024-05442-6 ↗
- Paper Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer. DOI 10.21037/atm-21-295 ↗
Kentaro Inamura · 1 shared paper, 2025 · strength 0.25
- Paper Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microe… DOI 10.21037/jgo-2025-283 ↗
Jing Li · 1 shared paper, 2025 · strength 0.25
- Paper Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microe… DOI 10.21037/jgo-2025-283 ↗
Jiayi Wang · 1 shared paper, 2025 · strength 0.25
- Paper Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microe… DOI 10.21037/jgo-2025-283 ↗
Elisa Giovannetti · 1 shared paper, 2025 · strength 0.25
- Paper Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microe… DOI 10.21037/jgo-2025-283 ↗
Meng Wang · 1 shared paper, 2024 · strength 0.20
- Paper KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. DOI 10.1007/s00018-024-05442-6 ↗
Li Ren · 1 shared paper, 2024 · strength 0.20
- Paper KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. DOI 10.1007/s00018-024-05442-6 ↗
Tianxing Zhou · 1 shared paper, 2024 · strength 0.20
- Paper KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. DOI 10.1007/s00018-024-05442-6 ↗
Jing Liu · 1 shared paper, 2024 · strength 0.20
- Paper KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. DOI 10.1007/s00018-024-05442-6 ↗
Ting Deng · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Rui Liu · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Zhi Ji · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Ning Wang · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Tiansuo Zhao · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Yi Ba · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Run-Fen Cheng · 1 shared paper, 2021 · strength 0.12
- Paper Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2020.0516 ↗
Rui Liu · 1 shared paper, 2021 · strength 0.12
- Paper Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2020.0516 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.